20245 Abstracts Information
SUBMISSION DEADLINE: August 15, 2025
NOTIFICATION DATE: August 22, 2025
Poster presentations convey innovative, clinically relevant information that enhances the professional skills of dermatology healthcare professionals treating patients with skin of color. The Skin of Color Update poster session provides presenting authors a forum in which they can showcase their work and interact with with the skin of color dermatology community. You are invited to submit poster abstracts for all relevant topics related to skin of color focused dermatology.
TOPIC AREAS
We invite all registered meeting attendees to submit posters of their latest research on the following topics:
- Aesthetic Dermatology
- Acne & Rosacea
- Alopecia Areata – Adults & Children
- Equity and Diversity in Dermatology
- Inflammatory Skin Conditions (Acne/Rosacea, Atopic Dermatitis, Eczema, Psoriasis)
- Keloids
- Nail Disorders
- Pediatric Dermatology
- Pigmentary Disorders (Melasma, Vitiligo, Hyperpigmentation, Photodamage)
- Seborrheic Dermatitis
WHO CAN SUBMIT
SOC Update accepts submissions from:
- Practicing Dermatologists
- Analysts
- Consultants
- Dermatology Residents
- Healthcare Providers
- Industry
- Dermatology Fellows
- Researchers
REVIEW PROCESS
Submitting parties receive automatic notification that the poster submission has been received. However, due to the high volume of submissions, additional acknowledgement may not be sent unless the poster is accepted by the review committee.
DEADLINE
Abstract Submission Deadline: August 15, 2025
Notification Date: August 22, 2025
FEES
Fee: No fee for non-industry-sponsored abstracts; $495 per abstract for industry-sponsored abstracts (non-refundable).
In order to display your poster at the meeting, one author or representative is required to register for Skin of Color Update. To view registration pricing and to register for the event, click here.
POSTER PRESENTATION
All accepted posters will be displayed at the Skin of Color Update, September 13-15, 2024, to be held at the New York Hilton Midtown, New York, NY.
In addition, approved abstracts will also be submitted and indexed through our partner brand Read by QxMD. The platform drives awareness, dissemination and engagement with this content via the Read by QxMD platform, as an educational tactic to drive CQI. ‘Read’ works on iPhone, iPad, Android smartphones & tablets and any web-enabled device (including desktops), and uses channels such as mobile, email and push notification to connect with our global community of healthcare providers and researchers.
If you are returning to complete or check the status of your submission, please sign-in HERE using your email address and password.
Encore posters are welcome!
Abstract Formatting and Content Guidelines
- Language: English
- Authors: full last name, first name, affiliations, degrees and contact information
-
- BOLD the name of the Presenting Author and include the Presenting Author’s contact information
- Font: Arial
- Maximum of 3000 characters, including spaces (not including the title, authors, or affiliations)
- Maximum of 2 relevant tables or figures submitted as attachments (not embedded in the file): must be 600 dpi .jpg
- Author(s) disclosures must be included to be considered.
- References must be included as parenthetical in-text citations – first author, et al, journal and year – (Cruz D, et al. Blood 2012)
- Full contact information of corresponding author (Please ensure that your email address is accurate, as all correspondence will be sent via email)
- Abstract text should preferably be in a “structured abstract” form with sections marked Background, Objectives, Methods, Results, Disclosures and Conclusions.
- Abstracts containing non-generic drug names or personal patient information, or reporting studies with unidentified chemical compounds, drugs, or materials, will not be accepted.
Please note that abstracts will not be accepted if the presenting author’s name is not bolded, presenting author’s email is not included and all faculty disclosures are not listed.
If you have any questions, please contact Medscape LIVE! at [email protected]
FAQs
Q&A FOR INDUSTRY-SUBMITTED ABSTRACTS
Q: Does the registered author need to be in attendance?
A: At least one (1) author (or representative) must be registered and in attendance for the in-person meeting to have their abstract(s) considered for poster display.
Q: Does the submitter need to be an author?
A: No
Q: Does the submitter need to be the registered author?
A: No
Q: Does the presenter need to be an author?
A: No, but the presenter must be registered.
Q: Can one representative present more than one poster?
A: Yes
Q: Is there a limit on the number of authors?
A: No
Q: Does the 3,000 characters include sections marked Background, Objectives, Methods, Results, Conclusions, and spaces only.
A: Yes, maximum of 3,000 characters, including spaces (does not include the title, authors, affiliations, disclosures).
Q: What format should the abstract(s) be submitted in?
A: Word only. PDF files are not accepted.
Q: Does the author(s) contact information and financial disclosures need to be included on the abstract? (add Q about posters)
A: Yes
Q: Are QR codes permitted on posters?
A: QR codes that link to additional information are permitted.
Q: Will posters be displayed as e-Posters, printed posters, or both?
A: Printed posters only.
Q: Is there a template for the poster?
A: No, there is no template. We only require the poster to be no larger than 4ft by 4ft.
Q: What is the embargo policy?
A: There is no policy.
Q: Are encore abstracts accepted?
A: Yes
Q: What is the copyright policy?
A: Copyright is shared. MedscapeLIVE! owns copyright for its own use. Author(s) retain rights for all other uses.
Q: Do poster(s) have to be submitted to MedscapeLIVE! in advance for approval?
A: No, you can bring your printed poster directly to the conference on the day of or ship it to the hotel. Further instructions will be provided in the acceptance email closer to the conference date.